The aim of this guideline is to provide general information about performing 18F-FDG PET or
PET/CT in inflammation and infection. We provide evidence for efficacy where it is available …

Sites of infection and inflammation can be misleading in oncology PET/CT imaging because
these areas commonly show 18 F-FDG activity. Caution in the interpretation must be taken to …

In the wake of the United States' regulations on the use of 18F-fluorodeoxyglucose (FDG),
the Spanish medicines regulatory agency last year stated that the use of FDG with PET …

For decades, conventional nuclear medicine techniques have been utilized for the
assessment of many infectious and inflammatory diseases. Most of these techniques have …

Purpose. To date, several meta-analyses have reported data about the diagnostic
performance of 18 F-FDG PET/CT in infectious and inflammatory diseases. This article aims …

Aim The diagnosis, severity and extent of a sterile inflammation or a septic infection could be
challenging since there is not one single test able to achieve an accurate diagnosis. The …

18F-FDG and 18F-FDG–labeled white blood cells (18F-FDG–WBCs) are valuable
radiopharmaceuticals for imaging focal sites of inflammation and infection. In the present …

White blood cells activated by either a pathogen or as part of a systemic inflammatory
disease are characterized by high energy consumption and are therefore taking up the …

Integrated positron emission tomography/computed tomography (PET/CT) with the glucose
analogue, 2-[18 F]-fluoro-2-deoxy-d-glucose (FDG), is an evolving hybrid imaging technique …

Nuclear medicine plays an important role in the evaluation of infection and inflammation.
Fluorine 18 fluorodeoxyglucose (FDG) is a readily available radiotracer that offers rapid …